Banyak announcement lah tak habis-habis cite ! Baca announcement nmpk SIOK je, tapi harga xdak naik ? Mcm TITIJAYA announcement dh lah LIMIT-UP, i rasa stock ini dh MATI PUCUK lah !!! Sape tau kasi URUT kuat-kuat biar stim dlu.......ni mcm esok.baru boleh naik kot.....
Tu lah David Coperfield. Kalau saya jadi Ozura, saya akan target nak jual saham pada harga lebih tinggi. Kalau sekadar keluarkan announcement projek sekadar nak tambah minat pelabur kecil terhadap saham, naikkan volume kemudian set pada harga 6 sen dengan 6.5 sen seperti batch pertama penjualan saham baru-baru ni, tak tahulah saya perancangan Ozura. Adakah pihak mereka ada plan lain seperti memberi peluang pihak lain membeli saham tersebut dengan harga yang sudah dikawal??????? Pelik juga, sepatutnya boleh dilaksanakan kenaikan harga saham memandangkan minat terhadap saham ini sebenarnya telah meningkat dan banyak announcement positif telah dapat dikeluarkan.
I did a rough calculation. 300 million shares at 0.06, equals to rm18 million. Now if 3000 off us were to buy 100k units at rm6k, the disposal will be over. Nexgram can fly. What u all think??
Sure can fly or not? i used 16 digit calculate kira 3 hari 2 mlm shares x habis jual lagi ! All medical stock up until down and this NEXGRAM still mimpin OZURA ! what wrong ?
Esok sape free? dtg beramai-ramai kita Pegi Bursa HQ, kali ini kita yg buat ANNOUNCEMENT dan panggil CNN international satu dunia orang tau, kita buat liputan announcement ini mcm baru boleh terbang kn
@David Coperfield. Kalau HWGB lah yang dapat announce contract macam yang terbaharu ni, mesti limit up punya. Nexgram, kalau tidak limit up pun sepatutnya gap-up. Tapi dalam keadaan macam ni saya sendiri kurang yakin. cuma harapnya gap-up lah sikit.
Nexgram in RM118m partnership with Central Spine Road sub-contractor Adam Aziz
theedgemarkets.com
August 17, 2020 20:20 pm +08
KUALA LUMPUR (Aug 17): Nexgram Holdings Bhd said today its wholly-owned unit Intra Binary Sdn Bhd (IBSB) is partnering Faldze Holdings Sdn Bhd (FHSB) for a sub-contract under the Central Spine Road project.
The project — awarded to FHSB from main contractor Pembinaan Jaya Zira Sdn Bhd — is Section D, Package 3 of the CSR project from Bulatan Gua Musang to Mentara, Kelantan worth RM145 million.
IBSB’s portion of the sub-contract, said Nexgram, is valued at RM118.41 million. On the other hand, FHSB’s portion entailed RM26.56 million inclusive of RM14.55 million provisional sum, it said.
Under the partnership, IBSB will provide funding and advise on project execution. It will also undertake the construction of the project.
FHSB, meanwhile, will come in for administration, procurement, technical assistance, and liaising with the main contractor.
IHSB and FHSB entered into an unincorporated joint venture agreement on Aug 14, Nexgram said.
like what MZM2511 said..must be something behind all these. Apa laa YG Kita boleh buat..bc announcement news do analysis culclation..unless we can do like @David Çoperfield said go to Bursa n call CNN..or panggil org ramai2 beli mcm jual durian Kat night market. ..so I dedicate laa lagu utk teman kita2 semua sementara NK tunggu esok..hehee NK gi jumpa Dato' Pon take no phone dia NK ajak minum kopi.
STILL REMEMBER EXACLY 1 MONTH AGO ...18 JULY...TOMOROW 18 AUGUST NEXGRAM EXPLODED BY 67 % FROM 3 SEN TO 5 SEN ...after BURSA GOT COMPUTER GLITCH due to TOP glove case.... HiSTORY TO REPEAT TOMOROW....GAP UP 67 % FROM 6 SEN = 10 SEN EXACTLY..... WATCH OUT TOMOROW NEXGRAM GAP UP 10 SEN WARRANTS ESPECIALLY EXPLOSIVE. WC. 7 SEN WB 6 SEN ,. WA. 6 SEN
The exciting ascent of Nexgram Biomedic began with development of TracvirusTM in March 2020, the company’s first clinical and laboratory health record management platform for mass screening and monitoring purposes by corporate and authorities. The company became the first Malaysian company independently developed an investigational anti-fraud and anti-fake Electronic Certificate specifically for Covid-19 test and vaccination records verification.
In addition, the company also cooperates with industry experts in the research for the development of drugs and vaccine for Covid-19, as well as other molecular diagnostic treatments for cancer, and anti-aging formulas.
We will jointly conduct clinical trials of your vaccine with Vacccineslab clinical development and commercialization capabilities in South East Asia Vaccineslab will commercialize the vaccine in South East Asia upon regulatory approval, with your firm retaining full rights to develop and commercialize the vaccine in the rest of the world Vaccineslab will secure funding and potential future investment and milestone payments, and share future gross profits from the sale of the vaccine in South East Asia
Nexgram Biomedic Sdn Bhd (NMed) is a global bio pharmaceutical company that develops new medical devices, drugs, and technologies in support of innovations in the medical field. NMed subsidiaries commenced research and development of new medical devices back in year 1993 as part of our search for the next-generation growth engine of Nexgram Group. The company’s hospital medical devices including face and body shield, surgical intubation and public protection devices, as well as disposable medical gloves and personal protection equipment are sold worldwide.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Sha711
151 posts
Posted by Sha711 > 2020-08-17 20:20 | Report Abuse
@niubee126 @MZM2511 @ David Çoperfield. thanks guys for ur support.